At Caltag, we offer a range of animal- and xeno-free products from trusted suppliers to support your research.
Animal- and Xeno-Free Research
Potent Neutralisation of Sars-CoV-2 Including Variants of Concern by Vaccines Presenting the Receptor-binding Domain Multivalently from Nanoscaffolds
RBD-SpyCatcher-mi3 vaccine construct could be a promising candidate for broad protection against SARS-CoV-2 variants, advocating for further clinical testing.
Discovery Of PF-06928215 As A High-Affinity Inhibitor of cGAS Enabled by a Novel Fluorescence Polarisation Assay
ProSci’s Custom Antibody Services were used to develop a mouse monoclonal antibody against cGAMP in a recent study.
Sensitive and Specific Immunohistochemistry Protocol for Nucleocapsid Protein from All Common SARS-CoV-2 Virus Strains in Formalin-Fixed, Paraffin Embedded Tissues
ProSci has generated several antibody reagents for SARS-CoV-2 research. Two of these antibodies were used in research by Yunguang Sun and colleagues.
Enhance your Research with ProSci’s Polyclonal Antibody Services
At ProSci, custom polyclonal antibodies are generated in various host species from customised immunogens designed by expert antibody scientists.
The Role of Monoclonal Antibodies & Biosimilars in Research
ProSci has more than 800 research-grade biosimilar antibodies in their catalogue and a team of custom antibody specialists providing expertise.
Does Your Research Require High-Quality and Consistent Rabbit Recombinant Antibodies?
ProSci offers a suite of services to develop rabbit recombinant antibodies with a defined structure, providing highly consistent & specific antibodies.
My Cites are Set on You!
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
Celebrating Excellence: ProSci Awarded ‘Rapid Star Winner’
ProSci Incorporated has been selected as the 2022 Bioz Stars Award Winner in the COVID-19 Category.
Immune Checkpoints
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.